Latest Breaking News On - Michael bogenschutz - Page 1 : comparemela.com

FDA Hosts Public Psychedelics Discussion, Discloses Major Growth On Number Of New Psychiatric Drugs Filings Post-2000 - Johnson & Johnson (NYSE:JNJ), Mind Medicine (NASDAQ:MNMD)

FDA and Reagan-Udall Foundation are hosting a virtual public meeting on psychedelic research titled Advancing Psychedelic Clinical Study Design, which aims to explore empirical approaches to address issues in drug development.

Public Safety Advocates Urge Newsom to Veto 'Dangerous' Bill Legalizing Psychedelics

California Bill Decriminalizing 'Magic Mushrooms' Passes Legislature, Awaiting Newsom's Signature

New FDA guidance on psychedelics changes little for local researchers but could open minds and funding sources

Plus: City Council passes mental health, affirmative care legislation Half of New Yorkers owe medical debts over $500, damaging their credit reports Meet the 2023 Notable Leaders in Advertising, Marketing and PR who work in health care

Federal Psychedelics: $75M Grant Program, NIDA's Special Interest In State & Local Reform

In view of the most recent Congressional advancement in psychedelics regulation, a bipartisan bill creating a $75 million research grant program for the potential treatment of mental health conditions in active duty mi